Eastern Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$143K Buy
369
+88
+31% +$35.1K ﹤0.01% 454
2026
Q2
$109K Buy
+281
New +$104K ﹤0.01% 494
2025
Q2
– Sell
-52
Closed -$22.6K – 962
2025
Q1
$22.6K Hold
52
– – ﹤0.01% 670
2024
Q4
$19.2K Sell
52
-7
-12% -$2.93K ﹤0.01% 700
2024
Q3
$30.7K Buy
+59
New +$31.5K ﹤0.01% 620

Other funds holding ELV

Eastern Bank's ELV Position: Q3 2026 in Review

Eastern Bank increased its Elevance Health (ELV) stake by 31% in Q3 2026, buying an estimated $35.1K and bringing the position to 369 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

Eastern Bank first reported a position in ELV in Q3 2024 and has held it in 5 quarters since. 1,031 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Eastern Bank held 369 shares of Elevance Health worth $143K as of Q3 2026.
  • Eastern Bank bought 88 Elevance Health shares in Q3 2026, an estimated $35.1K.
  • Elevance Health made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #454 holding.
  • Eastern Bank first reported a position in Elevance Health in Q3 2024 and has held it in 5 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.